AI Biomed PredictionsSPRO – Spero Therapeutics Nears Potential FDA Approval, Stock Poised to Surge Tony Fogleman / July 7, 2025
AI Biomed PredictionsCTMX – CytomX Set to Surge on Promising Cancer Trial Results Tony Fogleman / July 7, 2025
AI Biomed PredictionsETON – Eton Pharmaceuticals Set for Breakout Amidst Key FDA Approvals Tony Fogleman / July 7, 2025
AI Biomed PredictionsFF – FutureFuel: Strategic Shifts Poised for Q2 Catalyst Impact Tony Fogleman / July 7, 2025
AI Biomed PredictionsAGEN – Agenus Set for Breakout on Promising Phase 2 Cancer Trial Results Tony Fogleman / July 7, 2025
AI Biomed PredictionsICCC – ImmuCell Poised for Growth with Pending FDA Approval of Re-Tain Tony Fogleman / July 7, 2025
AI Biomed PredictionsAPVO – Aptevo Set to Transform with Upcoming AML Trial Results Tony Fogleman / July 7, 2025
AI Biomed PredictionsTXMD – TherapeuticsMD: Royalty Strategy Set to Catalyze Growth Tony Fogleman / July 7, 2025
AI Biomed PredictionsMTEX – Mannatech Gears Up for Strategic Growth and Market Expansion Tony Fogleman / July 7, 2025
AI Biomed PredictionsFTK – Flotek Poised for Breakout on Earnings Momentum Tony Fogleman / July 7, 2025
